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Abstract 
Background: To determine the incidence of 
surgical site infections(SSIs), and to document the 
causative organisms, duration of hospital stay, and 
therapeutic class of antibiotics administered in 
surgical prophylaxis in patients undergoing elective 
surgeries in Pakistan. 
Methods: In this multicenter observational study 
surgeons  were randomly selected. Surgical data 
from each investigator was collected from surgeries 
performed within a period of three months prior to 
the last month preceding the site initiation date. 
Patients 18 years of age or above, who had 
undergone elective surgeries that included 
gastrointestinal, biliary, pancreatic, urogenital, 
abdominal hernia, gynecologic procedures including 
caesarean section, were selected. The investigator 
collected data on last 10 consecutive patients 
preferably in the month between -2 and -
1.Recruitment list of 10% investigators was validated 
against the Operation theatre (OT) list. For each 
patient, data on demography, surgical information, 
antibiotic usage, SSI information and laboratory 
analysis was captured.The data was collected on a 
standardized case report form (CRF). The CRF was 
completed by the investigator/study coordinator.  
Results: Out of 858 patients, 71% were females. The 
mean age was 38.8±13.1 years. Three most common 
surgeries were gynecological including caesarean 
section (42.4%, 364/858), biliary (19.8%, 170/858) and 
abdominal hernia (18.4%, 158/858). In most cases 
(54.5%, 468/858), the duration of surgery was 
between 1–4 hours, and a majority (67.7%, 581/858) 
were classified as clean surgeries. In total, 6.5% 
patients (56/858) developed SSIs (95% confidence 
interval 5.1%-8.4%). All patients undergoing 
pancreatic surgery (n=3) developed SSI. Of the 
patients who developed SSIs 50% (28/56) developed 
it in post operative hospitalization period. The most 
common organisms isolated were Staphylococcus 
aureus (37.5%, 21/56), Escherichia coli (30.4%, 17/56) 
and Enterobacter (5.4%, 3/56). Significant mean 
difference (8.3±10.3 vs 3.3±2.9 days, p <0.001) in 
duration of hospital stay was observed in patients 
who developed SSI in comparison to those who did 
not. Cephalosporin (73.2%) was the most common 
therapeutic class used for prophylaxis, with third 
generation cephalosporin used in 60.7%. 
Conclusions: Periodic reporting of SSI rates is 
essential for international benchmarking and for 
strategizing efforts in reducing the associated 
healthcare burden in developing nations. 
Key Words: Surgical site infections. 
 
Introduction 
Surgical site infections (SSIs) are not only the most 
common complication following surgical procedures, 
but are also the most common type of nosocomial 
infections (NIs). They account for 20% of all 
healthcare-associated infections1, 2 and 38% of NIs 
among surgical patients.3A pilot study in Pakistan 
shows that 13% of patients who underwent elective 
surgery had SSIs.4 
As per the Centers for Disease Control and Prevention 
(CDC) National Nosocomial Infection Survey (NNIS) 
definition, a SSI is confirmed if one out of the 
following four criteria is fulfilled: (1) purulent 
drainage; (2) a positive culture result from wound 
swab; (3) local symptoms and opened by a surgeon, 
unless culture result is negative; (4) when the 
diagnosis is made by a surgeon or physician.5 SSI is 
also defined as an infection occurring in surgical 
wound within 30 days of operation.6 As per the 
classification by US CDC, SSIs have been categorized 
into three groups – superficial, deep, and organ/space 
infections.7 The four categories of surgical wounds (on 
the basis of degree of microbial contamination), 
namely – clean, clean-contaminated, contaminated and 
dirty, represent the increasing risk of SSIs.8 
SSIs are associated with adverse outcomes, which vary 
in severity depending on the category of surgical 
procedures.9 They lead to a failure in wound healing, 
thus contributing to increased duration of hospital 
stay, greater likelihood of admission to intensive care 
unit (ICU), mounting treatment costs, and higher 
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patient mortality.2,10 Patients with SSIs are 60% more 
likely to spend time in an ICU and 5 times more likely 
to be readmitted.11 SSIs are responsible for 77% deaths 
of surgical patients with NIs.3 
Periodic reporting of SSI rates is essential for 
international benchmarking and for strategizing efforts 
in reducing the associated healthcare burden in 
developing nations.A World Health Organization 
(WHO) report indicates that 66% of developing 
countries have no published data on the burden of 
SSIs.12 The published data of surgical prophylaxis for 
Pakistan is scant. The few pilot studies, documenting 
selected information on SSIs were conducted at single 
sites. The WHO suggests that studies from single 
hospitals cannot be considered representative of the 
epidemiology of health care associated infections in a 
given country. 12With a view to adopting measures to 
decrease the incidence of SSIs, the limited local 
literature necessitates the collection of data, and 
mandates surgical audits and wound surveillance.13  
An earlier cross-sectional study, National Audit of 
Surgical prophylaxis Pattern in Pakistan (NASPAK) , 
conducted in 2009 — to determine the rate of surgical 
prophylaxis administration, compliance of surgeons 
with clinical guidelines on surgical prophylaxis, and to 
document the therapeutic class of surgical 
antimicrobial prophylaxis administered in patients 
undergoing elective surgeries in Pakistan— did not 
necessarily reflect the overall practice at the hospital 
where the surgeon operated and did not collect any 
information pertaining to SSIs postoperatively, due to 
which SSI rates could not be determined (unpublished 
data).  
This retrospective nationwide study “Burden of 
SURGIcal site infections in elective surgeries in tertiary 
care hospitals in PAKistan (SURGIPAK) was therefore 
designed to collect information on the magnitude of 
SSIs, and to document the causative organisms, 
duration of hospital stay, and the therapeutic class of 
antibiotics administered in surgical prophylaxis in 
patients who underwent elective surgeries. 
 
Patients and Methods 
This was a multicenter observational study conducted 
in accordance with the principles laid by the 18th 
World Medical Assembly (Helsinki, 1964) and all 
subsequent amendments, and also guidelines for Good 
Epidemiology Practice. The investigators selected were 
surgeons operating in various public/private tertiary 
care hospitals in Pakistan. The investigators were 
randomly selected from a list of surgeons available 
with Sanofi Pakistan. The list of surgeons was 
validated against the list of surgeons obtained from 
College of Physicians and Surgeons (CPSP), a 
certifying and registration institution of surgeons in 
Pakistan. An investigator’s questionnaire was 
provided to the investigators to record their profile 
and information about surgical practice.  
Surgical data from each investigator was collected 
from surgeries performed within a period of three 
months prior to the last month preceding the site 
initiation date.Patients 18 years of age or above, who 
had undergone elective surgeries that included 
gastrointestinal, biliary, pancreatic, urogenital, 
abdominal hernia, gynecologic procedures including 
caesarean section, were selected. The surgeries had 
been performed within a period of three months prior 
to the previous month of the study. Patients were 
excluded if they had undergone emergency surgeries, 
pediatric surgeries, surgeries not mentioned in the 
inclusion criteria, orthopedic surgeries, wound 
dehiscence, fecal/biliary/urinary fistulas, surgeries for 
malignancies, or if data was missing on culture and 
susceptibility (wound and/or blood) in patients with 
SSIs, or if the surgeries were performed during the 
immediate last month to site initiation date.  
The investigator collected data on last 10 
consecutive patients preferably in the month 
between -2 and -1, who met inclusion/exclusion 
criteria (Fig 1). Recruitment list of 10% investigators 
was validated against the Operation theatre (OT) 
list. For each patient, data on demography, surgical 
information, antibiotic usage, SSI information and 
laboratory analysis was captured.The data was 
collected on a standardized case report form (CRF). 
The CRF was completed by the investigator/study 
coordinator.  
0 month 
Site initiation  
- 2 months- 3 months- 4 months - 1 month 
Preferable patient recruitment 
¦ Patients in exclusion criteria ;¦ Patients that can be included (Recruitment period)  
Figure 1: Period of patient recruitment 
 
Estimates from a pilot study conducted in Pakistan 
were used to determine the sample size. According to 
this study, 13% of patients who underwent elective 
surgery had SSIs.4 Assuming an error of 2% and 95% 
confidence level, data on 1100 patients was likely to 
provide an estimate of postoperative SSIs in Pakistan. 
Expecting 5% missing information in retrospective 
data, 1160 patients were considered sufficient to 
document the burden of SSIs. This sample size was 
also estimated to be sufficient to meet the secondary 
objectives. After data collection study documentation 
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including CRFs, screening log and OT list were 
dispatched to Sanofi affiliate head office, Karachi for 
double entry by data punch operator and data analysis 
by SPSS v.18 (IBM Corp, Sorners, NY, 
USA).Categorical data were analyzed for percentage 
distribution. Continuous data were reported as mean 
(±standard deviation [SD]), and comparison in mean 
difference between hospital stay (days) in patients 
who developed and did not develop SSIs was 
determined by using independent t-test. p-value <0.05 
was considered significant. 
Results 
The data were collected between19th May 2012 and 21st 
February 2013 from 84 sites (32 of the initially planned 
116 sites declined to submit the data towards the end 
of the study period). Seventy six sites provided data 
for 10 patients each and 8 sites provided data for more 
than 10 patients. In total, 1549 patients were screened, 
which yielded data for 893 patients, out of which data 
for 858 patients were evaluated and 
analyzed.Demographics and surgery 
characteristics:TheAnalyzed mean age of the study 
participants was 38.8 (± 13.1) years with women 
constituting a majority of the study population (71%). 
The three most common surgeries were gynecological 
including caesarean section (42.4%, 364/858), biliary 
(19.8%, 170/858), and abdominal hernia (18.4%, 
158/858) (Table 1). In most cases (54.5%, 468/858), the 
duration of surgery was between 1 to 4 hours, and a 
majority (67.7%, 581/858) were classified as clean 
surgeries (Table 1). 
In total, 6.5% patients (56/858) developed SSIs (95% 
confidence interval [CI] 5.1%-8.4%).  All patients 
undergoing pancreatic surgery (n=3) developed SSI. 
Patients undergoing gastrointestinal surgeries (13.6%, 
8/59),patients with dirty (50%, 2/4) and contaminated 
wounds (29.7%, 11/37) had a higher incidence of SSIs 
(Table 1).  
Of the patients who developed SSIs, 50% (28/56) 
patients developed it in the postoperative 
hospitalization period, whereas the other half 
developed it after discharge. The diagnosis of SSIs was 
made on the basis of purulent discharge from the 
incision in 50% (28/56) patients, surgeon diagnosing 
infection in 16.1% patients, deliberate opening of 
wound by surgeon in 8.9% patients, purulent 
discharge from the drain in 5.4% (3/56) patients, and 
organism isolated from culture of wound/blood in 
1.8% patients. More than one diagnostic criterion was 
used to diagnose SSI in 17.9% cases.Skin was involved 
in 28% patients, subcutaneous tissue was involved in 
26% and both skin and subcutaneous tissue were 
involved in 40% patients. Deep SSI was diagnosed in 
7% patients.   
In all but one patient (98.2%), the specimen used for 
culture reporting was collected from the wound; in 
one patient it was obtained from blood. In patients 
with SSIs, organisms were isolated in 83.9% (47/56) of 
the samples, the most common being Staphylococcus 
aureus (37.5%, 21/56), Escherichia coli (30.4%, 17/56) 
and Enterobacter (5.4%, 3/56) (Table 2). 
SSI developed after 6.8 (± 6.3) days of surgery. 
Surgical wound healed in 13.2 (+5.7) days in patients 
who developed SSI.Overall,33.9% (n=19) patients were 
re-hospitalized for an average of 8 (± 4.8) days. 
Patients who developed SSI showed significantly 
higher mean duration of hospital stay (days) than 
those who did not develop SSIs (8.3 ± 10.3 days vs 3.3 
± 2.9 days, p <0.001). 
Cephalosporin (73.2%) was the most common 
therapeutic class used for prophylaxis, with third 
generation cephalosporin used in 60.7%(Table 3).A 
combination of antibiotics was used in 23.8%,mostly in 
gynecological surgeries including caesarean section 
(12.8%) and gastrointestinal surgeries (3.7%). 
Intravenous route of administration was used in 
95.7%. Patients were administered first dose of 
antibiotic 68 (± 270) minutes prior to surgery. The 
prophylactic dose was administered within one hour 
prior to surgery in 83% and 8% received it at the time 
of incision. 
 
Table 1: Incidence of SSI and duration of 
antibiotic administration by type of surgery 
Type of Surgery  (n=858) (%) 
Duration of 
antibiotic 
use(days) 
 Mean+SD 
SSI 
(%) 
By wound classification  
  Clean 581 67.7 3.2 ± 2.9 4.0 
  Clean 
Contaminated 
233 27.2 
2.9 ± 2.2 
8.2 
  Contaminated  37 4.3 4.8 ± 3.2 29.7 
  Dirty 4 0.5 6.5 ± 5.5 50.0 
By anatomical site  
  Gynecology 
including   CS 
      364 42.4 3.3 ± 2.9 2.5 
  Biliary 170 19.8 3.0 ± 2.7 9.4 
  Abdominal 
Hernia 
158 18.4 2.6 ± 2.4 8.2 
  Urogenital 104 12.1 4.3 ± 3.2 9.6 
  Gastrointestinal 59 6.8 3.8 ± 2.6 13.6 
  Pancreatic 3 0.3 7.0 ± 2.6 100 
Abbreviations: SD, Standard Deviation; SSI, Surgical Site 
Infections; CS, Cesarean Section 
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The mean duration of antibiotic administration was 3.3 
(± 2.8) days. Antibiotics were used for a prolonged 
duration for urogenital surgeries (mean 4.3 ± 3.2 days). 
The longest duration of antibiotic use was in patients 
having dirty wounds (mean 6.5 ± 5.5 days) (Table 1). 
Irrespective of the type of surgeries, antibiotics were 
likely to be continued postoperatively. Antibiotics 
were continued postoperatively in 94%, (802/858) 
patients, for an average of 4 (± 3) days. In 91.1% 
(51/56) patients the same prophylactic antibiotic was 
continued postoperatively. This continuation was 
more common for gynecological surgeries including 
caesarean section (38.2%), biliary (19.5%) and 
abdominal surgeries (18.2%). 
 
Table 2: Organisms isolated from samples 
collected from wound swab or blood 
Organisms isolated N=56 (%) 
Staphylococcus aureus 21 37.5 
Escherichia coli  17 30.4 
Enterobacter 3 5.4 
Enterococcus  2 3.6 
Morganella catarrhalis 2 3.6 
Klebsiella 1 1.8 
Streptococcus 1 1.8 
 
Table 3: Distribution of patients who developed 
SSI by prophylactic antibiotic class 
administered 
Antibiotic class 
SSIs 
(N=56) 
(%) 
Mean Dose Mean 
duration 
±SD (days) ±SD (mg) 
Cephalosporins 
   1st  generation 2 3.6 750±353.5 3.0±2.8 
    2nd generation 5 8.9 1300.0±541.9 4.2±2.5 
    3rd generation 34 60.7 1080.8±293.3 5.2±5.1 
Metronidazole 9 16.1 1133.3±556.7 9.7±8.5 
Amoxicillin/Clav
ulanate 
5 8.9 1080.0±109.5 5.2±3.8 
Quinolone 2 3.6 350.0±212.1 22.0±0 
Penicillin 1 1.8 2000.0±0.0 3.0±0.0 
Aminoglycoside 2 3.6 1500.0±707.1 16.5±13.4 
Ampicillin 0 0 0.0±0.0 0.0±0.0 
Abbreviations: SD, Standard Deviation; SSI, Surgical 
Site Infections  
 
Discussion 
This multicenter  observational study showed  that 
6.5% patients undergoing elective surgeries in 
Pakistan develop SSIs. Patients undergoing 
gastrointestinal surgeries and patients with dirty and 
contaminated wounds have high incidence of SSIs. 
Staphylococcus aureus followed by Escherichia coli 
and Enterobacter are the most common causative 
organisms. The mean duration of hospital stay 
increases in patients with SSIs. The most common 
therapeutic class used for prophylaxis in patients who 
develop SSI is cephalosporin (73.2%) with third 
generation cephalosporin administered in 60.7% of the 
patients. Majority of patients are administered 
antibiotics by the intravenous route and receive the 
prophylactic dose within one hour prior to surgery. 
The rate of infection in a healthcare institution serves 
as a clinical indicator of the quality of service 
delivered.10 The incidence of SSIs observed in this 
study (6.5%) is similar to that (6.6%) reported by a 
study conducted in 2009-2010 in a medical college and 
hospital in Pakistan.13 However, it is lower than that 
(9.294%) reported by a study conducted in 2008-2009 
in a tertiary care facility in Pakistan.7 This variation in 
SSI rate may be due to differences in the characteristics 
of hospital population, the underlying diseases, 
differences in clinical procedures, the extent of 
infection control measures, and hospital 
environment.14 Our study shows the highest rate of 
SSIs (50%) in surgeries involving dirty wounds. 
Highest SSI rates are seen in gastrointestinal surgeries 
as most are dirty cases and these can be attributed to 
wound contamination by gut content.7,15 
Staphylococcus aureus(37.5%) was the most common 
organism isolated from samples of patients diagnosed 
with SSI; this was in line with other studies.16,17 
Escherichia coli and Klebsiella have been observed as 
the next most common organisms.10,13  Some other 
studies, show a slight deviation with Escherichia coli 
as the most common organism.1,2 Also, an alarming 
increase in Methicillin-Resistant Staphylococcus 
aureus (MRSA) has been observed, with 42% 
Staphylococcus aureus infections in Pakistan found to 
be methicillin-resistant.18 In addition,  gram-negative 
organisms like Escherichia coli isolated from  patients 
with SSIs have also shown an increasing resistance.19 
The available data thereby emphasizes the need for 
antimicrobials with a wide spectrum of activity, 
combined with low potential for resistance 
development, and activity against resistant and multi-
resistant strains.  
Patients who developed SSIs showed a significant 
difference in the mean duration of hospital stay as 
compared to those who did not develop SSIs (8.3 ± 
10.3 days vs 3.3 ± 2.9 days,p<0.001). This finding is 
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supported by several past reports. 13, 15A retrospective 
review in Europe, a prospective surveillance in 
Italy,and an observational study in India  report an 
additional length of 9.8, 11.1 and 9.98 days hospital 
stay, respectively, in SSI positive patients.17,20,21 The 
increased duration of hospital stay is a major 
contributor to the mounting costs of SSIs.22 Nearly one-
third of the patients in this study were re-hospitalized 
due to SSIs, further increasing the resource utilization 
attributable to SSIs. The clinical and economic burden 
caused by SSIs necessitates appropriate infection 
control interventions to provide valuable cost savings. 
 The duration of surgical procedure was ≤ 1 hour for 
44.1% (378/858) surgeries, between 1 to 4 hours for 
54.5% (468/858) surgeries, while seven surgeries 
(0.8%) lasted for > 4 hours. Prolonged duration of 
surgery increases risk of SSI, with higher rate seen in 
surgeries lasting more than 80 minutes  and more than 
150 minutes.8,13  Infection rate increases almost two 
times by every hour of operation23 with 6.3 times 
higher risk of wound infection with operations lasting 
for more than one hour.15 A higher frequency of SSIs 
was reported in caesarean sections lasting more than 
90 minutes.2 Similar results were seen in another 
study, with  2.6% SSI in surgeries of duration less than 
1 hour, 4.8% SSI in surgeries lasting between 1-2 hours 
and 5.4% SSI in surgeries of more than 2 hours 
duration.24 Mangram AJ et al therefore affirm the 
duration of surgery as one of the three reliable 
predictors of SSI risk.3 
In our study, the most common therapeutic class used 
for prophylaxis in patients who developed SSI, was 
cephalosporin (73.2%), with third generation 
cephalosporins administered in 60.7% patients. Our 
findings are in line with the observations made in the 
NASPAK registry conducted in 2009 wherein 
cephalosporins (n=743, 81.0%) were the most common 
therapeutic class used for surgical prophylaxis and 
third generation cephalosporins were the most 
preferred antibiotics (unpublished data). Earlier 
studies (conducted in 2010 and 2013) have also 
reported that third generation cephalosporins are 
prescribed most frequently (64.74% and 64.40% pre- 
and post-operatively, respectively).21,25It is evident that 
the cephalosporins have remained the most commonly 
used class of antibiotics over the past few years, 
probably because of their favorable pharmacokinetic 
profiles, low incidence of adverse effects and low 
costs.26 
The study covered a varied spectrum of surgical 
settings as it was conducted in 84 centers across 
Pakistan involving both public and private sector 
hospitals, thus providing diversity, to the 
results.Design of the study allows collection of patient 
follow-up data such as duration of postoperative 
antibiotic use. However, despite best efforts the target 
sample size could not be achieved (it was planned to 
evaluate a sample of 1100 patients, but only 858 
patients were evaluated). Therefore further studies 
with adequate sample sizes need to be conducted to 
extrapolate these results to the population.  
 
Conclusion 
1.This study demonstrates that 6.5% patients develop 
SSI after elective surgeries in Pakistan. Staphylococcus 
aureus is the most common causative organism. 
2.Majority of patients undergoing elective surgery in 
Pakistan receive antibiotic prophylaxis. 
Cephalosporin, especially third generation 
cephalosporin are most widely used for prophylaxis in 
patients with SSI.   
3.SSIs are associated with increased morbidity and 
mortality in surgical patients, thus imposing an 
extensive clinical and economic burden on a 
developing economy. Raising awareness at different 
levels, among local/national authorities and the 
public, calls for efforts in periodic reporting of SSIs 
rates and for international benchmarking. 
4.Studies on the use of antibiotics in surgical 
prophylaxis need to be conducted to aid in monitoring 
and detecting the changing susceptibility patterns for 
SSIs that may require modification of antibiotic usage. 
5.Standardizing surveillance protocols and enhancing 
funding of multimodal, multicenter or national 
intervention programs, and WHO-directed 
interventions, may result in increased overall patient 
safety and substantial reductions in healthcare 
expenditure related to SSIs.  
 
Acknowledgements 
We would like to thank the following participating 
physicians who recruited patients – 
Gulzar Ahmed(Bahawalpur);Asrar Ahmad 
Khan(Faisalabad);Dilawiez 
Ahmed(Faisalabad);GhulamMahboobSubhani(Faisalabad);
Muhammad Yasin(Faisalabad);Shahbaz Ahmad(Faisalabad); 
Bashir Ahmad(Faisalabad); Asadullah Malik( Faisalabad); 
Muhammad Akram(Faisalabad); Faisal Bilal 
Lodhi(Faisalabad); FakharHameed(Faisalabad); Haji Akhter( 
Gujranwala);AftabMunir( Hyderabad);AmbreenAmna, 
(Hyderabad); Chandra Madhudas(Hyderabad); 
FehmeedaMemon(Hyderabad);FirdousMumtaz(Hyderabad)
;Furkhanda Habib(Hyderabad); Gulfarin Khan( 
Hyderabad); Hira Shah(Hyderabad); SanoberShaikh 
(Hyderabad); Summaya Israr(Hyderabad); Farana 
Journal of Rawalpindi Medical College (JRMC); 2015;19(3):209-214 
 
 214 
Anjum(Hyderabad); M Paryal Taggar(Hyderabad); Nishat 
Zehra(Hyderabad); Nusrat Lakho (Hyderabad); Pushpa 
Sirichand (Hyderabad); Sajda Yusfani (Hyderabad); Shazia 
Rani (Hyderabad);  Rahil Rahman(Karachi); Iffat Javed( 
Karachi); Yasmeen Nauman (Karachi);Ahmad Raza 
(Lahore); Farogh Zahra(Lahore); Javed Sheikh (Lahore); 
Kamran Chaudhry(Lahore);  Mansoor A Qureshi (Lahore); 
Muhammad Naeem( Lahore); ShabnamAsif, (Lahore); 
TouseefAsghar (Lahore); Ehsan-ur-Rehman(Lahore); 
JavedShakir(Lahore); Lubna Riaz Dar (Lahore); Safia 
Munir(Lahore); Malik Hussain Jalbani (Larkana); 
ShahidRao( Multan); Syeda Ali( Multan); Hajira 
Sultana(Multan); Muhammad Ayub( Multan); M Sajjad 
Masood(Multan); Mehnaz Khakwani (Multan); Saira Ayub 
(Multan); Sajjad Masood(Multan); Shahida Parveen 
(Multan); Abdul Qayyum(Peshawar); Ali Gohar(Peshawar); 
Imran Khan(Peshawar); Muhammad Muslim(Peshawar); 
Mah Munir(Peshawar);  Hizbullah Jan (Peshawar); Ihsan- 
ur- Rehman(Peshawar); Muhammad Asghar( Peshawar); 
Mir Alam Jan (Peshawar); NaeemMumtaz( Peshawar); 
Parveen Naveed (Peshawar); Rukhsana Karim (Peshawar);  
Sajjad M Khan (Peshawar), Shahid Safdar(Rahim Yar Khan); 
Tariq Mehmood Rehan (Rahim Yar Khan); Arifa Manzoor 
(Rawalpindi);  Atif Khan (Rawalpindi); Aurangzaib, 
(Rawalpindi); Faryal Gohar (Rawalpindi); Muhammad 
Hanif ( Rawalpindi); NasiraTasneem (Rawalpindi); Safdar 
Shah (Rawalpindi); Sajid Mumtaz Qazi (Rawalpindi); 
Shagufta Sayal (Rawalpindi); Shahid 
Safdar(Rawalpindi);Usman Qureshi (Rawalpindi); Zahida 
Perveen, (Rawalpindi);  Ziyad Afzal Kiyani 
(Rawalpindi).The authors acknowledge the assistance of Dr. 
Alina Gomes and Anahita Gouri with editing of the 
manuscript, references and figures, supported by Sanofi.  
References 
1. Jan WA, Khan SM, Jehanzeb M, Muazzam M. Surgical Site 
Infection And Pattern Of Antibiotic Use In A Tertiary Care 
Hospital In Peshawar. J Ayub Med Coll Abbottabad 2010; 
22(3):270-73    
2. Ansar A. Surgical Site Infection in Obstetrics Practice. 
Journal of Surgery Pakistan 2013; 18(2): 
3. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. 
Guideline For Prevention Of Surgical Site Infection. 20(4), 
1999. 
4. Sangrasi AK . Surgical site infection rate and associated risk 
factors in elective general surgery at a public sector medical 
university in Pakistan. International Wound Journal 
2008;5(1):74-78. 
5. Krukerink M, Kievit J, Marang-van de Mheen PJ. Evaluation 
of routinely reported surgical site infections against 
microbiological culture results: a tool to identify patient 
groups where diagnosis and treatment may be improved. 
BMC Infectious Diseases 2009; 9:176-79. 
6. Ansar A. Surgical Site Infection in Obstetrics Practice. 
Journal of Surgery Pakistan 2013;18(2) 
7. Khan M . Rate and risk factors for surgical site infection at a 
tertiary care facility in Peshawar, Pakistan. J Ayub Med Coll 
Abbottabad. 23(1), 2011:95-99  
8. Bandaru NG, Rao RA, Prasad VK, Murty R.  A prospective 
study of postoperative wound infections in a teaching 
hospital of rural setup. Journal of Clinical and Diagnostic 
Research 2012; 6(7):1266-71.  
9. Coelho R, Charlette A, Wilson J, Ward V, Pearson A, 
Borreillo P. Adverse impact of surgical site infections in 
English hospitals. Journal of Hospital Infection 2005; 60:93–
103, 2005.  
10. Afifi IK, Labah EA, Ayad KM. Surgical site infections after 
elective general surgery in Tanta University Hospital: Rate, 
risk factors and microbiological profile. Egyptian Journal  
of Medical Microbiology 2009; 18(2):98-101 
11. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE. The 
impact of surgical-site infections in the 1990s: attributable 
mortality, excess length of hospitalization, and extra costs. 
Infect Control Hosp Epidemiol 199; 20:725-30,1999. 
12. WHO Report on the Burden of Endemic Health Care –
Associated Infection Worldwide. A systemic review of the 
literature. Available 
at:http://whqlibdoc.who.int/publications/2011/97892415
01507_eng.pdf.   
13. Awan MS, Dhari FJ, Laghari AA, Bilal F, Khaskheli NM. 
Surgical Site Infection In Elective Surgery.Journal of Surgery 
Pakistan2011; 16(1):49-52  
14. Kamat US, Fereirra AMA, Kulkarni MS and Motghare DD: A 
prospective study of surgical site infections in a teaching 
hospital in Goa. Indian J. Surg 2008; 70:120–24.  
15. Varik K, Kirisimagi U, Varimae EA, Eller M. Incidence and 
risk factors of surgical wound infection in children. 
Scandinavian Journal of Surgery 2010;. 99: 162–66.  
16. Pal N and Guhathakurtha R. Surgical site infection in 
surgery ward at a tertiary care hospital: the infection rate 
and the bacteriological profile. IOSR Journal of Pharmacy 
2012; 2(5):01-05 
17. Leaper DJ. Surgical site infection — a European perspective 
of incidence and economic burden. Int Wound J  
2004;1(4):247-73. 
18. Bukhari SZ, Ahmed S, Zia N. Antimicrobial susceptibility 
pattern of Staphylococcus Aureus on clinical isolates and 
efficacy of laboratory tests to diagnose MRSA: A  multi-
centre study.J Ayub Med Coll Abbottabad 2011;23(1):29-32 
19. Kusachi S . Isolated bacteria and drug susceptibility 
associated with the course of surgical site infections. J Infect 
Chemother 2007; 13:166–71.  
20. Prospero E, Cavicchi A, Bacelli S, Barbadoro P. Surveillance 
for surgical site infection after hospital discharge: A surgical 
procedure–Specific perspective.Infection Control and 
Hospital Epidemiology 2006;27(12):936-40 
21. Rana DA, Malhotra SD, Patel VJ. Inappropriate surgical 
chemoprophylaxis and surgical site infection rate at a 
tertiary care teaching hospital.  Braz J Infect Dis 2013; 
17(1):48–53.  
22. Jenks PJ, Laurent M, Mcquarry S, Watkins R. Clinical and 
economic burden of surgical site infection (SSI) and 
predicted financial consequences of elimination of SSI from 
an English hospital. Journal of Hospital Infection 2014; 
86:24-29  
23. Cruse PJ and Foord R. The epidemiology of wound infection. 
A 10-year prospective study of 62,939 wounds.Surg Clin 
North Am 1980; 60(1):27-40. 
24. Anvikar AR, Deshmukh AB, Karyakarte RP.A one year 
prospective study of 3280 surgical wounds.Indian J Medical 
Microbiol 1999; 17(3):129–32.  
25. Rehan HS, Kakkar AK, Goel S. Surgical antibiotic prophylaxis 
in a tertiary care teaching hospital in India. Int J Infect 
Control 2010; 6(2):1-6. 
26. Shanmugam S, Acharya LD, Mallayasamy SR, Rao A, Khan 
SA, Rajakannan T. Study of tissue and the plasma 
concentrations of Cefotaxime to assess its suitability for 
prophylaxis in Cholecystectomy.Journal of Clinical and 
Diagnostic Research 2010;(4):2410-14. 
 
